Visalytics
Visalytics
approved EB-2 (NIW)

Associate Scientist

Biomedical Engineering · China · 2023-09-20

Processing Time
2 days
Decision Date
2023-09-20
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on developing complex in vitro models focusing on therapeutic methods targeting soft tissue. This work specifically aims to study cancer- and infection-induced immune responses and assess kinase inhibitors to reduce bleeding risks associated with platelet deposition inhibition.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses significant national health concerns like leukemia and improves patient healthcare outcomes through safer drug development.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a record of published research in top journals that is widely relied upon in the field.

3 Waiver Benefit Met

The petitioner's work in a critical and emerging technology field supported by NIH funding makes a waiver of the job offer requirement beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in chemical and biomolecular engineering and a record of 3 peer-reviewed journal articles with 26 citations. The case satisfied all three Dhanasar prongs, supported by funding from the National Institutes of Health (NIH) and 4 expert recommendation letters.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Government Alignment

Similar Cases

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 60 days 2025-02-15
The petitioner proposes to use advanced in vitro functional approaches to study disease mechanisms and identify drug targets for cancer, obesity, and autoimmune disorders. Her work specifically focuses on advancing personalized cancer treatments by identifying precise drug targets and improving immune regulation.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 289 days 2025-02-26
The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Research Scientist

Biotechnology · Greece

WeGreened EB-2 (NIW) approved
Washington 117 days 2023-02-01
The petitioner proposes to design technological infrastructure for new, cost-effective, industry-grade tools that interface with and house human tissue. This work focuses on advancing the development of novel disease treatments and vaccines by modeling human tissues and their response to vaccination agents.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-09-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 2 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist